MyMD Pharmaceuticals announced that it received notice from Nasdaq on March 4 informing the company that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550 for continued listing on the Nasdaq Capital Market.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on MYMD: